This mutation was also observed in sequence data generated from benign precursor regions (n = 4), suggesting that the ALPK1 p.V1092A mutation may be an early founder/truncal mutation, or is associated with a field change, as has been widely reported for other cancers, particularly skin22. Here, ALPK1 is linked to cancer.